We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.4B
AUM Growth
+$153M
(+0.69%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-4.8%
Top 10 Holdings %
Top 10 Hldgs %
13.8%
Holding
1,474
New
155
Increased
445
Reduced
544
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Conagra Brands
CAG
|
+$72.5M |
| 2 |
ConocoPhillips
COP
|
+$70M |
| 3 |
PepsiCo
PEP
|
+$60.2M |
| 4 |
TJX Companies
TJX
|
+$57.6M |
| 5 |
Dollar General
DG
|
+$57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$122M |
| 2 |
Starbucks
SBUX
|
+$69M |
| 3 |
Altria Group
MO
|
+$64.7M |
| 4 |
RTX Corp
RTX
|
+$63.2M |
| 5 |
UBS Group
UBS
|
+$56.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.92% |
| 2 | Technology | 12.76% |
| 3 | Miscellaneous | 10.7% |
| 4 | Financials | 10.43% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Ionis Pharmaceuticals
IONS
$7.85B
| $8.21M | 0.04% |
352,549
-14,467
| -4% | -$467K |
|
427
Las Vegas Sands
LVS
$26.7B
| $8.16M | 0.04% |
187,641
+116,607
| +164% | +$5.45M |
|
428
MDU Resources
MDU
$3.91B
| $8.14M | 0.04% |
892,320
-912,570
| -51% | -$7.43M |
|
|
ACH
429
Accendra Health
ACH
$86.9M
| $8.08M | 0.04% |
216,200
-16,900
| -7% | -$635K |
|
|
MDSO
430
DELISTED
Medidata Solutions, Inc.
MDSO
| $8.02M | 0.04% |
171,000
+22,300
| +15% | +$972K |
|
431
iShares Core MSCI EAFE ETF
IEFA
$193B
| $7.89M | 0.04% |
152,000
| – | – |
|
432
AGCO
AGCO
$8.67B
| $7.85M | 0.04% |
166,500
+12,500
| +8% | +$642K |
|
|
GGP
433
DELISTED
GGP Inc.
GGP
| $7.8M | 0.03% |
261,438
-73,640
| -22% | -$2.08M |
|
434
Baxter International
BAX
$12.3B
| $7.71M | 0.03% |
170,406
-13,496
| -7% | -$592K |
|
435
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.1B
| $7.7M | 0.03% |
62,750
-310
| -0.5% | -$37.2K |
|
436
Integra LifeSciences
IART
$1.22B
| $7.68M | 0.03% |
192,648
+80,368
| +72% | +$2.89M |
|
437
Ameriprise Financial
AMP
$49.4B
| $7.65M | 0.03% |
85,100
+47,800
| +128% | +$4.62M |
|
|
NBL
438
DELISTED
Noble Energy, Inc.
NBL
| $7.64M | 0.03% |
212,973
-15,151
| -7% | -$532K |
|
439
Henry Schein
HSIC
$9.75B
| $7.64M | 0.03% |
110,160
-3,315
| -3% | -$224K |
|
|
MDVN
440
DELISTED
MEDIVATION, INC.
MDVN
| $7.58M | 0.03% |
125,778
-23,228
| -16% | -$1.32M |
|
441
Ambev
ABEV
$46.7B
| $7.56M | 0.03% |
1,279,536
+64,108
| +5% | +$344K |
|
|
SPLS
442
DELISTED
Staples Inc
SPLS
| $7.55M | 0.03% |
876,224
-497,600
| -36% | -$4.74M |
|
443
Netflix
NFLX
$325B
| $7.55M | 0.03% |
825,000
| – | – |
|
444
HDFC Bank
HDB
$116B
| $7.54M | 0.03% |
454,536
| – | – |
|
445
CoreCivic
CXW
$3.5B
| $7.53M | 0.03% |
215,110
-315,190
| -59% | -$10.3M |
|
446
Intercontinental Exchange
ICE
$88.1B
| $7.4M | 0.03% |
144,500
| – | – |
|
|
ELGX
447
DELISTED
Endologix Inc
ELGX
| $7.4M | 0.03% |
59,362
+818
| +1% | +$94K |
|
448
Hormel Foods
HRL
$11.4B
| $7.38M | 0.03% |
201,600
-1,400
| -0.7% | -$52.4K |
|
449
American Electric Power
AEP
$65.6B
| $7.36M | 0.03% |
105,000
+12,500
| +14% | +$818K |
|
450
Leidos
LDOS
$16.2B
| $7.35M | 0.03% |
153,600
-33,820
| -18% | -$1.67M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2016 Portfolio in Review
As of Q2 2016, Axa held 1,474 positions worth $22.4B, up 0.69% from $22.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.08B in Q2 2016, closing 111 positions and reducing 544 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $23.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Axa opened a new position in Willis Towers Watson worth $32.3M.
- Axa's largest Q2 2016 buy was Willis Towers Watson: 260,003 shares worth $32.3M.
- Axa added most to Conagra Brands in Q2 2016, an estimated $72.5M increase.
- Axa's biggest Q2 2016 reduction was St Jude Medical, cutting an estimated $122M.
- Axa fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $23.5M.
- Axa's ten largest holdings make up 14% of its $22.4B portfolio in Q2 2016.
- Axa opened 155 new positions and closed 111 in Q2 2016.
- Axa's portfolio value rose 0.69% quarter-over-quarter to $22.4B.
Based on Axa's 13F filing for Q2 2016, filed 11 Aug 2016.